Research-grade retatrutide occupies the next tier
Summary: Retatrutide FDA Status Retatrutide is not FDA-approved and won't be for at least another year It's in Phase 3 trials (TRIUMPH program) with results expected in late 2026 FDA approval is projected for 20272028 Phase 2 data showed 24.2% weight loss , better than any approved GLP-1 medication Current access: clinical trials (free), compounded retatrutide ($200$500/mo), or research peptides ($150$500/mo) When approved, retatrutide will be the first triple-agonist obesity medication on the market References Jastreboff AM, Aronne LJ, Ahmad NN, et al
Home B12 INJECTION B12 INJECTION Recommended Add-Ons: B12 can be added to almost any infusion for an extra boost of energy Benefits Energy, Energy, Energy Decreases Fibromyalgia Symptoms Prevents Pernicious Anemia (caused by B12 deficiency) Corrects B12 deficiency caused by gastric bypass, vegetarian diets, and other conditions What are vitamin B12 injections used for
Functional consequences of age-dependent changes in glutathione status in the brain